Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Arthur J. Atkinson; Wayne A. Colburn; Victor G. DeGruttola; David L. DeMets; Gregory J. Downing; Daniel F. Hoth; John A. Oates; Carl C. Peck; Robert T. Schooley; Bert Spilker; Janet Woodcock; Scott L. Zeger

doi:10.1067/mcp.2001.113989

Keywords

Surrogate endpointCitationMedicineOriginal researchComputer scienceLibrary scienceInternal medicine

Affiliated Institutions

National Institutes of Health US

Related Publications

Surrogate endpoints in clinical trials: Definition and operational criteria

Ross L. Prentice

Abstract I discuss the idea of using surrogate endpoints in the context of clinical trials to compare two or more treatments or interventions in respect to some ‘true’ endpoint,...

1989 Statistics in Medicine 1985 citations

Surrogate End Points in Clinical Trials: Are We Being Misled?

Thomas R. Fleming

Phase 3 clinical trials, which evaluate the effect that new interventions have on the clinical outcomes of particular relevance to the patient (such as death, loss of vision, or...

1996 Annals of Internal Medicine 1607 citations

Meta-analysis for the evaluation of potential surrogate markers

Michael J. Daniels , Michael D. Hughes

We describe a meta-analysis approach for the evaluation of a potential surrogate marker. Surrogate markers are useful in helping to identify therapeutic mechanisms of action and...

1997 Statistics in Medicine 343 citations

Surrogate Markers in AIDS: Where Are We? Where Are We Going?

Stephen W. Lagakos , Daniel F. Hoth

Editorials1 April 1992Surrogate Markers in AIDS: Where Are We? Where Are We Going?Stephen W. Lagakos, PhD, Daniel F. Hoth, MDStephen W. Lagakos, PhD, Daniel F. Hoth, MDAuthor, A...

1992 Annals of Internal Medicine 76 citations

Evaluating surrogate markers.

Michael D. Hughes , Victor DeGruttola , Seth L. Welles

We discuss approaches for efficiently evaluating potential surrogate markers; in particular, we focus on case-cohort designs in which marker evaluation is undertaken only for a ...

1995 PubMed 29 citations

Publication Info

Year: 2001
Type: review
Volume: 69
Issue: 3
Pages: 89-95
Citations: 6487
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

6487

OpenAlex

Cite This

APA Style

                            
                                
                                    Arthur J. Atkinson, 
                                
                                    Wayne A. Colburn, 
                                
                                    Victor G. DeGruttola
                                
                                et al.
                            
                            (2001). 
                            Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. 
                            Clinical Pharmacology & Therapeutics
                            , 69
                            (3)
                            , 89-95.
                            https://doi.org/10.1067/mcp.2001.113989
                        

Identifiers

DOI: 10.1067/mcp.2001.113989